Fabian Schnitzler - Concepedia

Author

Fabian Schnitzler

Ludwig-Maximilians-Universität München ORCID

Also Known As

F Schnitzler, F. Schnitzler, Fabian Schnitzler, Fabian Schnitzler (578498), Schnitzler, Fabian

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Ludwig-Maximilians-Universität München Universitair Ziekenhuis Leuven University of Liège Zimmer Biomet (Germany)LMU Klinikum

About

Fabian Schnitzler is an author at Ludwig-Maximilians-Universität München specializing in medicine, gastroenterology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	332
2	Gastroenterology	5	5	332
3	Immunology	4	4	304
4	Pathology	4	4	317
5	Obstetrics	1	1	15

Fabian Schnitzler

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease Fabian Schnitzler, Herma H. Fidder, Marc Ferrante, Inflammatory Bowel Diseases	2009	669
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort Fabian Schnitzler, Herma H. Fidder, Marc Ferrante, Gut	2008	530
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study Herma H. Fidder, Fabian Schnitzler, Marc Ferrante, Gut	2008	448
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis Ingrid Arijs, K. Li, Gary Toedter, Gut	2009	399
Long-term outcome after infliximab for refractory ulcerative colitis Marc Ferrante, Séverine Vermeire, Herma H. Fidder, Journal of Crohn s and Colitis	2008	221
Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy Fabian Schnitzler, Herma H. Fidder, Marc Ferrante, Inflammatory Bowel Diseases	2011	198
Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease Matthias Jürgens, Jestinah Mahachie John, Isabelle Cleynen, Clinical Gastroenterology and Hepatology InflammationChronic Inflammatory DiseasesAutoimmune DiseaseImmunologyGastroenterology	2011	191
Predictors of early response to infliximab in patients with ulcerative colitis Marc Ferrante, Séverine Vermeire, Maja Noman, Inflammatory Bowel Diseases	2006	190
Disease Activity, ANCA, and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis Matthias Jürgens, Rüdiger P. Laubender, Franziska Hartl, The American Journal of Gastroenterology	2010	169
Polymorphisms in the <i>DLG5</i> and OCTN cation transporter genes in Crohn’s disease Helga‐Paula Török, Jürgen Glas, L Tonenchi, Gut	2005	161

Page 1